RT Journal Article
SR Electronic
A1 Lederman, Lynne
T1 Vosaroxin in Combination With Cytarabine Provides a New Salvage Option for AML
JF MD Conference Express
YR 2014
FD SAGE Publications
VO 14
IS 55
SP 15
OP 16
DO 10.1177/1559897715570843
UL http://mdc.sagepub.com/content/14/55/15.abstract
AB The addition of vosaroxin to cytarabine improves overall survival and complete remission rates in patients with relapsed, refractory acute myeloid leukemia. This combination is not associated with increased early mortality. Patients at least age 60 years seemed to benefit more than younger patients.